NCT01392794View on ClinicalTrials.gov

A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
HealthyPlasma Concentration of YM060
Interventions
DRUG

YM060

oral, without water

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY